am 251 and jzl195
am 251 has been researched along with jzl195 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Anderson, WB; Gould, MJ; Mitchell, VA; Torres, RD; Vaughan, CW | 1 |
Crews, FT; Grant, ML; Jones, VM; Khatri, D; Laroche, G; Mukhopadhyay, S; Vetreno, RP | 1 |
Other Studies
2 other study(ies) available for am 251 and jzl195
Article | Year |
---|---|
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.
Topics: Amidohydrolases; Analgesics; Analysis of Variance; Animals; Arthritis, Experimental; Benzamides; Benzoxazines; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice; Mice, Inbred C57BL; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Piperazines; Piperidines; Pyrazoles; Time Factors | 2014 |
Acute Ethanol Inhibition of Adult Hippocampal Neurogenesis Involves CB1 Cannabinoid Receptor Signaling.
Topics: Animals; Binge Drinking; Cannabinoids; Carbamates; Caspase 3; Cell Death; Cell Proliferation; Doublecortin Domain Proteins; Doublecortin Protein; Drug Interactions; Endocannabinoids; Ethanol; Hippocampus; Ki-67 Antigen; Male; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Piperazines; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2018 |